Syringocystadenoma Papilliferum Syringocystadenoma papilliferum (SCAP) is a rare, benign, adnexal neoplasm that typically presents as a single, red to brown plaque. The lesion may have ulcerations, ...

Perlman Katherine, L. and Kentosh Joshua, B. (2021) Syringocystadenoma papilliferum du cuir chevelu. Dermatology Online Journal, 27, Article No. 14.

Townsend, T.C., Bowen, A.R. and Nobuhara, K.K. (2004) Syringocystadenoma Papilliferum An Unusual Cutaneous Lesion in a Pediatric Patient. The Journal of Pediatrics ...

A woman in her 60s presented with an asymptomatic, nodule over the left side of the scalp, slowly growing over a period of 1 year. It was associated with occasional oozing and an episode of bleeding.

Ceruminous syringocystadenoma papilliferum is an extremely rare lesion in the EAC, only a dozen of cases were reported (12 – 16). It specifically contains papillae lined by two-layered epithelium ...

Dear Editor, Syringocystadenoma Papilliferum (SCAP) is an uncommon benign adnexal tumor that originates from pluripotent cells with either apocrine or eccrine sweat gland differentiation. Around 50% ...

We, the U.S. Fish and Wildlife Service (Service or USFWS), are correcting one amendatory instruction in a final rule that published in the Federal Register on May 4, 2023. That rule finalizes the ...

The diagnosis of vulvar disorders depends upon clinical history, physical examination, and, in some instances, confirmation with laboratory evaluation. The focus of this classification was on ...

Moreover, hidradenoma papilliferum (HP), a tumor thought to originate from apocrine glands or mammary glands, can occasionally occur on the vulva and cause pruritus (84). In one series, HP represented ...

This case report presents a case in which a collision tumor consisting of three separate pathological entities—a verrucous carcinoma (VC), syringocystadenoma papilliferum (SCAP), and a basal cell ...

In a few cases it may give rise to a tumor, either benign, such as the syringocystadenoma papilliferum, or malignant, including squamous cell or basal cell skin carcinoma.